TransCode Therapeutics
Stock Forecast, Prediction & Price Target

TransCode Therapeutics Financial Estimates

TransCode Therapeutics Revenue Estimates

TransCode Therapeutics EBITDA Estimates

TransCode Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $9.7M
Low: $9.7M
High: $9.7M
avg. 0%
Avg: $9.9M
Low: $9.9M
High: $9.9M
avg. 2.06%
Net Income
 
% change YoY
$-6.93M
 
N/A
$-35.12M
 
-406.30%
$-18.54M
 
47.20%
Avg: $-119.93K
Low: $-119.93K
High: $-119.93K
avg. 99.35%
Avg: $-84.13K
Low: $-84.13K
High: $-84.13K
avg. 29.85%
Avg: $-82.34K
Low: $-82.34K
High: $-82.34K
avg. 2.12%
Avg: $-69.81K
Low: $-69.81K
High: $-69.81K
avg. 15.21%
EBITDA
 
% change YoY
$-5.82M
 
N/A
$-17.46M
 
-199.61%
$-17.97M
 
-2.90%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$658.8
 
N/A
-$2,195.62
 
-233.27%
-$103.61
 
95.28%
Avg: -$0.67
Low: -$0.67
High: -$0.67
avg. 99.35%
Avg: -$0.47
Low: -$0.47
High: -$0.47
avg. 29.85%
Avg: -$0.46
Low: -$0.46
High: -$0.46
avg. 2.12%
Avg: -$0.39
Low: -$0.39
High: -$0.39
avg. 15.21%
Operating Expenses
 
% change YoY
$5.87M
 
N/A
$17.58M
 
199.43%
$19.41M
 
10.42%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is TransCode Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 36.63% in 2025-2028.

We have gathered data from 1 analysts. Their low estimate is -119.93K, average is -119.93K and high is -119.93K.

What is TransCode Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 0.51% in 2025-2028.

We have gathered data from N/A analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is TransCode Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 36.63% in 2025-2028.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.67, average is -$0.67 and high is $-0.67.